Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,817,545
-
Share change
-
+359,155
-
Total reported value
-
$9,770,551
-
Put/Call ratio
-
267%
-
Price per share
-
$2.02
-
Number of holders
-
53
-
Value change
-
+$1,056,686
-
Number of buys
-
29
-
Number of sells
-
18
Institutional Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q4 2024
As of 31 Dec 2024,
Fortress Biotech, Inc. - COM NEW (FBIO) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,817,545 shares.
The largest 10 holders included
Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, PVG ASSET MANAGEMENT CORP, ENVESTNET ASSET MANAGEMENT INC, SHIKIAR ASSET MANAGEMENT INC, Kestra Advisory Services, LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and CITADEL ADVISORS LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.